Dianthus Therapeutics (DNTH) Other Non Operating Income: 2022-2025
Historic Other Non Operating Income for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to -$360,000.
- Dianthus Therapeutics' Other Non Operating Income fell 650.00% to -$360,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$947,000, marking a year-over-year decrease of 245.62%. This contributed to the annual value of -$554,000 for FY2024, which is 551.76% down from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Other Non Operating Income is -$360,000, which was down 236.45% from -$107,000 recorded in Q2 2025.
- Dianthus Therapeutics' Other Non Operating Income's 5-year high stood at $56,000 during Q3 2022, with a 5-year trough of -$382,000 in Q4 2024.
- For the 3-year period, Dianthus Therapeutics' Other Non Operating Income averaged around -$115,818, with its median value being -$80,000 (2024).
- Its Other Non Operating Income has fluctuated over the past 5 years, first slumped by 1,166.67% in 2024, then climbed by 14.04% in 2025.
- Dianthus Therapeutics' Other Non Operating Income (Quarterly) stood at -$20,000 in 2022, then crashed by 60.00% to -$32,000 in 2023, then slumped by 1,093.75% to -$382,000 in 2024, then slumped by 650.00% to -$360,000 in 2025.
- Its last three reported values are -$360,000 in Q3 2025, -$107,000 for Q2 2025, and -$98,000 during Q1 2025.